SCHEME 1.
Schematic of preparation of Gel‐GFP‐Mutation‐M33‐M47 BDVs combined with PD‐1 antibody for immunotherapy of melanoma. (a) Preparation process of Gel‐BDVs. (b) Effector T cell were actived by Gel‐GFP‐Mutation‐M33‐M47 BDVs to against melanoma
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.